By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...